| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327701 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
The combination of gemcitabine and carboplatin is active and feasible in platinum-sensitive patients with recurrent ovarian cancer. This regimen is undergoing further evaluation in a large phase III trial.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
M.F. Kose, J. Sufliarsky, S. Beslija, P. Saip, G. Tulunay, K. Krejcy, T. Minarik, E. Fitzthum, A. Hayden, A. Melemed,